ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,728.53
0.00%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Evelo Biosciences Inc (EVLO)

  7. Evelo Biosciences Inc (EVLO) Noticias

EVLO

Evelo Biosciences (EVLO)

Evelo Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:EVLO
FechaHoraFuenteTítuloSímboloCompañía
26/01/202416:30Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:EVLOEvelo Biosciences Inc
26/01/202416:29Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EVLOEvelo Biosciences Inc
26/01/202416:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:EVLOEvelo Biosciences Inc
26/01/202416:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVLOEvelo Biosciences Inc
12/12/202306:43Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:EVLOEvelo Biosciences Inc
12/12/202306:42Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:EVLOEvelo Biosciences Inc
01/12/202306:11Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:EVLOEvelo Biosciences Inc
09/11/202316:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EVLOEvelo Biosciences Inc
08/11/202319:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EVLOEvelo Biosciences Inc
17/10/202306:00GlobeNewswire Inc.Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate PsoriasisNASDAQ:EVLOEvelo Biosciences Inc
21/08/202316:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:EVLOEvelo Biosciences Inc
17/08/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EVLOEvelo Biosciences Inc
14/08/202306:30GlobeNewswire Inc.Evelo Biosciences Announces Second Quarter Financial Results and Recent Business HighlightsNASDAQ:EVLOEvelo Biosciences Inc
10/08/202315:02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:EVLOEvelo Biosciences Inc
18/07/202306:27IH Market NewsTuesday’s Wall Street Highlights: Novartis, BofA, Dollar General, Uber, Masimo and moreNASDAQ:EVLOEvelo Biosciences Inc
12/07/202315:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EVLOEvelo Biosciences Inc
12/07/202306:30GlobeNewswire Inc.Evelo Biosciences Closes $25.5 Million Private PlacementNASDAQ:EVLOEvelo Biosciences Inc
10/07/202306:30GlobeNewswire Inc.Evelo Biosciences Announces $25.5 Million Private PlacementNASDAQ:EVLOEvelo Biosciences Inc
29/06/202308:00GlobeNewswire Inc.Evelo Biosciences Announces Reverse Stock Split EffectiveNASDAQ:EVLOEvelo Biosciences Inc
23/06/202315:55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVLOEvelo Biosciences Inc
12/06/202315:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EVLOEvelo Biosciences Inc
12/06/202307:22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:EVLOEvelo Biosciences Inc
16/05/202305:00PR Newswire (US)Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of BiomimicryNASDAQ:EVLOEvelo Biosciences Inc
10/05/202316:12Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:EVLOEvelo Biosciences Inc
28/04/202315:23Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:EVLOEvelo Biosciences Inc
28/04/202315:20Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:EVLOEvelo Biosciences Inc
18/04/202316:24Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:EVLOEvelo Biosciences Inc
18/04/202316:10Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:EVLOEvelo Biosciences Inc
16/03/202307:30Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EVLOEvelo Biosciences Inc
16/03/202306:00GlobeNewswire Inc.Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsNASDAQ:EVLOEvelo Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:EVLO

Su Consulta Reciente

AMEX
SPY
SPDR S&P 500
CCOM
SILVER
SILVER
FX
USDMXN
US Dollar vs MXN
NASDAQ
NVDA
NVIDIA
FX
EURMXN
Euro vs MXN
COIN
ETHUSD
Ethereum
PM
XAUUSD
Gold vs US Dollar
NYSE
AXP
American Express
USOTC
BNPQY
BNP Paribas (QX)
FX
EURUSD
Euro vs US Dollar
NYSE
CVX
Chevron
USOTC
RHHBY
Roche (QX)
COIN
SOLUSD
Solana
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
BTCUSD
Bitcoin
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados